Kolkata, West Bengal -- (SBWIRE) -- 09/16/2013 -- Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on Orexigen Therapeutics, Inc. (NASDAQ:OREX), Vringo, Inc.(NYSEAMEX:VRNG), Xerox Corporation (NYSE:XRX).
Orexigen Therapeutics, Inc. (NASDAQ:OREX) shares dropped 1.34% and closed at $6.64 in the last trading session. The company announced that management was scheduled to present a company overview at the Bank of America Merrill Lynch Global Healthcare Conference in London. The presentation is scheduled for Thursday, September 12(th) at 9:30 a.m. London Time.
Additionally, the company on August 27 announced that the Light Study independent Data Monitoring Committee has recently confirmed that sufficient major adverse cardiovascular events (MACE) are expected to occur within the next two months, enabling the interim analysis to be conducted by early December and the potential resubmission of the Contrave® New Drug Application (NDA) by year end.
Should Investors Buy OREX After Yesterday’s Jump? Find Out Here
Vringo, Inc.(NYSEAMEX:VRNG) shares decreased 0.65% to $3.05. The company on Sept. 12 announced that its wholly owned subsidiary, Vringo Infrastructure, Inc., filed a patent infringement lawsuit against The ADT Corporation, ADT LLC, ADT Security Services, Inc., and Tyco Integrated Security, LLC in United States District Court for the Southern District of Florida.
The lawsuit alleges infringement of U.S. Patent No. 6,288,641, entitled "Assembly, and Associated Method, for Remotely Monitoring a Surveillance Area" ("the '641 Patent"). The '641 Patent relates to, amongst other things, the use of a mobile terminal to remotely monitor a location (e.g., home or business).
How Should Investors Trade VRNG After The Recent Volatility? Get Free Trend Analysis Here
Xerox Corporation (NYSE:XRX) shares jumped 3.06% to $10.45. To help insurers process complex pharmacy claims that vary by state and insurer, Xerox on Sept. 11 said it has launched a pharmacy benefits management (PBM) program with Cypress Care, a division of Healthcare Solutions, Inc. A pilot of the program reduced the average pharmacy spend for the insurer per claim by 33 percent and increased the number of pharmacy bills entering the specialized PBM program by 49 percent.
Additionally, The company on Sept. 3 said it has processed and disbursed more than $1.7 billion in federal incentives to healthcare providers who use electronic health records. Providers apply for the incentives using a secure, web-based tool from Xerox to show that they have implemented and used EHRs under federal guidelines.
Is XRX A Good Buy After The Recent Price Movement? Find Out Here
Specialpennystockalert.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Specialpennystockalert.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.
The assembled information disseminated by Specialpennystockalert.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Specialpennystockalert.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)